Unformatted text preview: MEDICATION
Nonsteroidal anti- inflammatory
REVIEW MODULE CHAPTER
PURPOSE OF MEDICATION
Expected Pharmacological Action
Inhibition of cyclooxygenase : inhibition
of cox-2 results in decreased inflammation,
Decrease inflammation, analgesia for mild to
moderate pain, fever reduction, dysmenorrhea,
fever and pain.
inhibition of platlet aggregation.
GI upset impaired renal function, increase risk for
Take with milk, food or
heart attack / stroke.
water to reduce Gl upset.
parenterally then switched
to oral dose.
Pregnancy, peptic ulcer disease, bleeding disorders
children w/ viral infections, older adult clients, clients
taking : gluccocorticoids, anticoagulants, ace inhibitors
Ke torolac should not be used in clients w/advanced
monitor PPT, PT, INR
Ketorolac & other NSAIDS should not be used
Concurrently. Should not be used longer than 5
days b/c of the risk for Kidney damage.
Advise client to tell HOP
Evaluation of Medication Effectiveness
about and OTC medication
depending on theraputic intent.
vitamins or herbal supple -
Reduction in inflammation, Reduction of fever, Relief
from mild to moderate pain, absence of injury.
Advise client not to chew
or crush enteric coated
F I FARNING TEMPI ATFS...
View Full Document
- Fall '17
- Pharmacology, Non-steroidal anti-inflammatory drug, Cyclooxygenase